Biotest
Dr. Ulrike Wippermann has a comprehensive background in various roles within the medical and scientific fields. With a strong educational foundation from Ludwig-Maximilians-Universität München, Dr. Wippermann has held positions ranging from Junior Product Manager to Senior Manager Corporate Medical Affairs at Biotest AG. Additionally, Dr. Ulrike has experience as a Scientific Associate in Production Diagnostics and as a Postdoctoral Research Associate at Technische Universität München.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.